Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
uniQure Inc.
uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
June 25, 2026
uniQure Announces Pricing of Upsized $225 Million Public Offering
June 23, 2026
uniQure Announces $150 Million Proposed Public Offering
June 22, 2026
uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy
June 19, 2026
uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease
June 17, 2026
uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates
May 24, 2026
uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease
May 24, 2026
uniQure to Announce First Quarter 2026 Financial Results
May 24, 2026